• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [22358 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2015     Belgian Health Care Knowledge Centre (KCE) Autologous breast reconstruction techniques after mammary resection time measurements for a potential re-evaluation of the surgeon fee
2015     NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab monotherapy for relapsed and refractory multiple myeloma
2015     NIHR Health Technology Assessment programme A systematic review and economic evaluation of intraoperative tests [RD-100i one-step nucleic acid amplification (OSNA) system and Metasin test] for detecting sentinel lymph node metastases in breast cancer
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Umeclidinium/vilanterol (as trifenatate) (Anoro® Ellipta®)
2015     NIHR Health Technology Assessment programme Development of processes allowing near real-time refinement and validation of triage tools during the early stage of an outbreak in readiness for surge: the FLU-CATs Study
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Perceval S sutureless valve for aortic valve replacement: a review of the clinical effectiveness, safety, and cost-effectiveness
2015     NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dolutegravir/abacavir/lamivudine (Triumeq®)
2015     NIHR Health Services and Delivery Research programme Measuring prevalence, reliability and variation in high-risk prescribing in general practice using multilevel modelling of observational data in a population database
2015     NIHR Horizon Scanning Centre (NIHR HSC) Gemtuzumab ozogamicin (Mylotarg) with conventional chemotherapy for acute myeloid leukaemia – first line
2015     Institute for Clinical Effectiveness and Health Policy (IECS) Corneal endothelial keratoplasty for the treatment of corneal endothelial dysfunction
2015     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial
2015     NIHR Health Technology Assessment programme Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Bedaquiline (Sirturo®)
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Development of a preference-based instrument: Asian Comparative Study]
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Rituximab for granulomatosis with polyangiitis or microscopic polyangiitis: a review of the clinical and cost-effectiveness
2015     NIHR Horizon Scanning Centre (NIHR HSC) MABp1 (Xilonix) for metastatic colorectal cancer –third line
2015     Institute for Clinical Effectiveness and Health Policy (IECS) Equine therapy and other Equine-related therapies in developmental disorders, autism spectrum disorders and cerebral palsy
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Entecavir (Baraclude®)
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Economic evaluation of carotid artery stenting compared with carotid endarterectomy in patients with carotid artery stenosis]
2015     NIHR Horizon Scanning Centre (NIHR HSC) Obinutuzumab (Gazyvaro) for indolent non-Hodgkin lymphoma – first line, in combination with chemotherapy
2015     Institute for Clinical Effectiveness and Health Policy (IECS) [Hair micro transplant using follicular unit extraction technique for alopecia]
2015     Basque Office for Health Technology Assessment (OSTEBA) [An evaluation of the efficacy of psychosocial techniques (cognitive rehabilitation vs. psychoeducation) as an additional treatment to pharmacological treatment in bipolar disorder]
2015     NIHR Health Technology Assessment programme A systematic review and economic evaluation of exercise referral schemes in primary care: a short report
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Daclatasvir (Daklinza®)
2015     National Evidence-based Healthcare Collaborating Agency (NECA) [Handbook for clinical practice guideline developer]
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Excimer laser and stenting in patients with distal peripheral arterial disease: a review of the clinical effectiveness, safety, and guidelines
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep (Reolysin) with or without chemotherapy for metastatic malignant melanoma – second line
2015     Institute for Clinical Effectiveness and Health Policy (IECS) Mechanical insufflation-exsufflation assisted coughing in neuromuscular diseases
2015     NIHR Health Technology Assessment programme The impact of Cochrane Reviews: a mixed-methods evaluation of outputs from Cochrane Review Groups supported by the National Institute for Health Research
2015     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Defibrotide (Defitelio®)
2015     NIHR Horizon Scanning Centre (NIHR HSC) Pelareorep (Reolysin) in combination with chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck – second line
2015     Institute for Clinical Effectiveness and Health Policy (IECS) Cervical arthroplasty for degenerative intervertebral disc disease
2015     Basque Office for Health Technology Assessment (OSTEBA) [Telemonitoring multi-pathological chronic patients with heart or lung disease. Evaluation of the implementation in Primary Care]
2015     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Tonsillectomy, adenoidectomy and adenotonsillectomy for obstructive sleep apnoea: review of clinical evidence and guidelines
2016     NIHR Health Technology Assessment programme Psychoeducation with problem-solving (PEPS) therapy for adults with personality disorder: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manualised intervention to improve social functioning
2016     NIHR Horizon Scanning Centre (NIHR HSC) Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Impact evaluation of optimal use guidelines implementation for self-monitoring of blood glucose by adult patients with type 2 diabetes and not using insulin]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Blinatumomab - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Intrathecal idursulfase (Elaprase) for Hunter syndrome (mucopolysaccharidosis type II)
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides for the pharmacological treatment of STBBIs]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Carfilzomib - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nusinersen for paediatric-onset spinal muscular atrophy – first line
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Extracorporeal photopheresis: main indications and implementation parameters]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Fingolimod (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Eculizumab (Soliris) for refractory myasthenia gravis
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal long-term use of proton pump inhibitors]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Aflibercept (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Voke 0.45mg inhaler for smoking cessation – first line
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Magnetic resonance spectroscopy and magnetic resonance imaging with tractography for psychiatric disorders
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Rectal cancer investigation, treatment and follow-up algorithm]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Regorafenib - Addendum to Commission A15-43]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Crisaborole for adults, adolescents and children with atopic dermatitis
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Prostate bipolar transurethral resection for the treatment of benign prostatic hyperplasia
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Colon cancer investigation, treatment and follow-up algorithm (update)]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Netarsudil for open-angle glaucoma or ocular hypertension
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Eculizumab in nocturnal paroxysmal hemoglobinuria and atypical hemolytic-uremic syndrome
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Feasibility and appropriateness of implementing satellite radiotherapy centres equipped with a single linear accelerator]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lumacaftor/ivacaftor - Assessment according to §35a (para. 1., sentence 10) Social Code Book V]
2016     NIHR Health Technology Assessment programme The Ankle Injury Management (AIM) trial: a pragmatic, multicentre, equivalence randomised controlled trial and economic evaluation comparing close contact casting with open surgical reduction and internal fixation in the treatment of unstable ankle fractures in patients aged over 60 years
2016     NIHR Horizon Scanning Centre (NIHR HSC) Mitomycin ophthalmic (Mitosol) for glaucoma surgery
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Augmentative and alternative communication device with eye tracking (TOBII) in language and motor speech disorders
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Evidence brief on the measures related to the reimbursement of blood glucose test strips]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for a DMP "rheumatoid arthritis"]
2016     NIHR Health Services and Delivery Research programme Improving skills and care standards in the support workforce for older people: a realist synthesis of workforce development interventions
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Enzyme replacement therapy in Gaucher Disease
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Effect of palivizumab prophylaxis in reducing the complications associated with the respiratory syncytial virus in infants and young children]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Secukinumab (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Health Services and Delivery Research programme Integrated care to address the physical health needs of people with severe mental illness: a rapid review
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Sacubitril in combination with valsartan for chronic heart failure
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib - Benefit assessment according to §35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) An enhanced recovery after surgery program for hip and knee arthroplasty
2016     NIHR Health Technology Assessment programme Modelling disease progression in relapsing remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort
2016     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of heated humidified high-flow nasal cannula compared with usual care for preterm infants: systematic review and economic evaluation
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Endoscopic radiofrequency ablation in gastroesophageal reflux disease
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Circulating tumour cells in breast cancer: clinical use of the CellSearch® test]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Efmoroctocog alfa - Benefit assessment according to § 35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) LINX reflux management system
2016     Agency for Healthcare Research and Quality (AHRQ) Diabetes medications for adults with type 2 diabetes: an update
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound of peripheral nerves
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical practice guidelines for the rehabilitation of adults having sustained a moderate to severe traumatic brain injury: development process and recommendations]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Rilpivirine (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Cryotherapy, radioablation and irreversible electroporation for prostate cancer
2016     Agency for Healthcare Research and Quality (AHRQ) Imaging for the pretreatment staging of small cell lung cancer
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Positron emission tomography/magnetic resonance imaging (PET/MRI) in cancer
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Standards regarding reperfusion treatments for ST-segment elevation acute myocardial infarction (STEMI) in Quebec]
2016     Institute for Clinical Effectiveness and Health Policy (IECS) [Vemurafenib for the treatment of pediatric patients with braf v600e mutation-positive ganglioglioma]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Crizotinib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) CT to reduce negative appendectomy rates
2016     Belgian Health Care Knowledge Centre (KCE) Left ventricular assist devices in the treatment of end-stage heart failure
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Ultrasound-guided sclerotherapy with foam in chronic vein insufficiency
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Clinical guides in antibiotic treatment – 1st series (update)]
2016     Institute for Clinical Effectiveness and Health Policy (IECS) [Bariatric surgery to treat obesity with a body mass index (BMI) less than 40 kg/m2]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sacubitril/valsartan - Benefit assessment according to §35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Retrograde endovascular balloon occlusion of the aorta (REBOA)
2016     NIHR Health Technology Assessment programme UK FASHIoN: feasibility study of a randomised controlled trial of arthroscopic surgery for hip impingement compared with best conservative care
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Anti-mog (myelin oligodendrocyte glycoprotein) antibodies for the diagnosis of optic neuromyelitis and other demyelinating diseases
2016     Institut national d'excellence en sante et en services sociaux (INESSS) [Economic evaluation of the molecular diagnosis of the influenza virus]